A Randomized Controlled Trial of Neurocognitive and Supportive Therapy Interventions for Individuals With Parkinson's Disease
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Parkinson's Disease
- Sponsor
- Virginia Commonwealth University
- Enrollment
- 32
- Locations
- 1
- Primary Endpoint
- California Verbal Learning Test-II Long Delay Free Recall Scaled Score Change Over 10 Weeks
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
This randomized, controlled trial (RCT) evaluates the benefits of memory and problem solving training compared to supportive therapy in individuals with Parkinson's Disease with Mild Cognitive Impairment (MCI) and their support persons. Participants will be randomly assigned to receive memory and problem solving training or supportive therapy for 2-months. A 6-month follow up evaluation will establish if benefits remain over time. Impact of these therapies on thinking abilities, physical health, and patient and support person ratings of thinking skills, mood and quality of life will be evaluated. The memory and problem solving training is hypothesized to result in greater improvements and/or stability of function on neuropsychological tests of attention, working memory, learning, and memory skills compared to the supportive therapy condition. Both conditions are hypothesized to result in improved mood and quality of life ratings.
Results from this study will determine whether memory and problem solving therapies and supportive therapy are easily used by and beneficial for individuals with Parkinson's Disease and Mild Cognitive Impairment. If positive benefit is observed, information from this study will be used to further optimize these therapies for larger trials designed to evaluate the value of the therapies for individuals with Parkinson's Disease and their support persons.
Detailed Description
The memory and problem solving training consists of a day calendar manual and note taking system and problem solving techniques. The supportive therapy offers patients and support persons the opportunity to discuss and reflect upon both Parkinson's Disease and non-Parkinson's Disease related problems.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Clinical diagnosis of Parkinson's Disease
- •Clinical diagnosis of Mild Cognitive Impairment
Exclusion Criteria
- •Clinical diagnosis of Dementia
- •Clinical diagnosis of other Parkinson's Disease-associated comorbid conditions (e.g., severe anxiety, depression, excessive daytime sleepiness, or psychosis) that significantly influence cognitive testing
Outcomes
Primary Outcomes
California Verbal Learning Test-II Long Delay Free Recall Scaled Score Change Over 10 Weeks
Time Frame: Change from Baseline in California Verbal Learning Test-II Long Delay Free Recall Scaled Score at 10 weeks
Change in California Verbal Learning Test-II Long Delay Free Recall Scaled Score from Baseline and 10 weeks
Secondary Outcomes
- Linear Analog Scale Assessment Overall Well Being Raw Score Change Over 10 Weeks(Change from Baseline in Linear Analog Scale Assessment Overall Well Being Raw Score at 10 weeks)